kabutan

Watahan & Co.,Ltd.(3199) Summary

3199
TSE Prime
Watahan & Co.,Ltd.
1,417
JPY
-3
(-0.21%)
Jan 29, 2:49 pm JST
9.25
USD
Jan 29, 12:49 am EST
Result
PTS
outside of trading hours
1,416.9
Jan 29, 2:59 pm JST
Summary Chart Historical News Financial Result
PER
11.9
PBR
1.14
Yield
2.12%
Margin Trading Ratio
25.39
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
1,425 JPY 9.30 USD
Previous Close Jan 28
1,420 JPY 9.30 USD
High Jan 29, 9:00 am
1,425 JPY 9.30 USD
Low Jan 29, 9:16 am
1,406 JPY 9.17 USD
Volume
31,000
Trading Value
0.04B JPY 0.29M USD
VWAP
1412.21 JPY 9.23 USD
Minimum Trading Value
141,700 JPY 925 USD
Market Cap
0.03T JPY 0.18B USD
Number of Trades
151
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
Mid
1-Year Average
97
1-Year High Oct 28, 2025
371
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 6,300 22,600 3.59
Jan 16, 2026 5,900 14,300 2.42
Jan 9, 2026 6,100 16,100 2.64
Dec 26, 2025 7,600 16,800 2.21
Dec 19, 2025 4,600 22,800 4.96
Company Profile
Watahan & Co.,Ltd. operates home centers primarily in Nagano Prefecture, handling food products including some fresh items. The company is also involved in roof renovation and trading businesses.
Sector
Retail Trade
Watahan & Co.,Ltd. focuses on three main business segments: retail, construction, and trading. In the retail segment, the company operates various store formats centered around supercenters, offering a wide range of products from fresh food to home center merchandise. The company pursues low prices and freshness through its EDLP strategy and direct procurement. It also operates multiple e-commerce platforms. The construction segment covers a wide range of services, including wooden construction, steel frame building, interior and exterior work, and the construction of automated multi-story parking facilities. The company's strengths lie in its proprietary construction methods and integrated in-house production system. In the trading segment, Watahan imports and sells pharmaceutical and chemical raw materials, and manufactures active pharmaceutical ingredients for fertility treatments. Additionally, the company engages in comprehensive building management and real estate transactions.